| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.042 | 0.3 |